There was no statistically significant difference in the subjective ( 92.2 % vs 94.2 % ; P = .78 ; difference , 2.0 % ; 95 % confidence interval , -2.7 % to +6.7 % ) or objective ( 94.4 % vs 96.7 % ; P = .50 ; difference , 2.3 % ; 95 % confidence interval , -1.5 % to +6.1 % ) cure rates between MiniArc and Monarc at 12 m , respectively , with a significant improvement in overactive bladder outcomes and incontinence impact from baseline in both arms .